The Electric Wheelchair Market, estimated at USD 9.65 Bn in 2025, is expected to exhibit a CAGR of 11% and reach USD 20.03 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on adopting growth strategies such as product launches, which is expected to drive the global electric wheelchair market. For instance, in August 2025, Invacare Corporation, one of the global leaders in the manufacture and distribution of innovative home and long-term care medical products, announced the launch of the Invacare AVIVA STORM RX power wheelchair, setting a new standard for rear-wheel drive power mobility.
Global Electric Wheelchair Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025" or COVID-19. The virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.
COVID-19 had a negative impact on the global electric wheelchair market due to Several factors including the increased risk of being discharged from COVID-19 treatment while hospital beds, supplies, and staff were in short supply and many states did not designate this population as a priority when vaccines got emergency use authorisation which is expected to drive the growth of the global electric wheelchair market. For instance, in October 2025, the National Council on Disability, a free-standing government organization dedicated to leading in the field of disability police , published data according to which, People with intellectual or developmental disabilities, as well as medically fragile and technology-dependent people, faced a high risk of being triaged out of COVID-19 treatment when there were not enough hospital beds, supplies, or staff available. They were occasionally refused the help of essential support persons while hospitalized, as well as the usage of their personal ventilator machines after being admitted. Both informal and official Crisis Standards of Care (CSC) pronouncements, which guided the distribution of limited healthcare resources in surge situations, singled out people with certain disabilities for denial of care.